Immunis Inc.
Immunis is a private biotechnology company dedicated to researching and developing multi-active biologics to address age-driven diseases and immune dysfunction. The company focuses on immunomodulatory secretome therapeutics to improve immune system health, muscle regeneration, and metabolic functions, aiming to change the course of aging and immune-related diseases.
Industries
Nr. of Employees
small (1-50)
Immunis Inc.
Irvine, California, United States, North America
Products
Cell‑free stem cell‑derived secretome therapeutic for muscle regeneration
A multi‑factor, cell‑free biologic derived from the secretome of partially differentiated human stem cells; formulated and processed to provide standardized concentrations of immunomodulatory proteins, growth factors and remodeling molecules for intramuscular delivery to improve muscle mass, strength and metabolism.
Cell‑free stem cell‑derived secretome therapeutic for muscle regeneration
A multi‑factor, cell‑free biologic derived from the secretome of partially differentiated human stem cells; formulated and processed to provide standardized concentrations of immunomodulatory proteins, growth factors and remodeling molecules for intramuscular delivery to improve muscle mass, strength and metabolism.
Services
Clinical development of cell‑free secretome therapeutics
Conducts translational development and early‑phase clinical studies to evaluate safety, tolerability and preliminary efficacy of secretome‑derived biologics for age-related muscle and metabolic disorders.
Clinical development of cell‑free secretome therapeutics
Conducts translational development and early‑phase clinical studies to evaluate safety, tolerability and preliminary efficacy of secretome‑derived biologics for age-related muscle and metabolic disorders.
Expertise Areas
- Multi‑active biologics development
- Secretome‑derived therapeutics
- Clinical trial management (Phase I/II)
- Preclinical translational research (aged models)
Key Technologies
- Stem cell‑derived secretome products
- GMP cell culture and partial differentiation
- Secretome harvesting and potency standardization
- Intramuscular administration